| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
DNA Repair Group, Institute of Plant Genetics and Crop Plant Research, D-06466 Gatersleben [K. B., C. M. G.], and Division of Applied Toxicology, Institute of Toxicology, Medical Faculty, University of Mainz, D-55131 Mainz [B. K.], Germany
Chloroethylnitrosoureas (CNUs) are being used in the therapy of various neoplastic diseases, including skin cancer. Because secondary tumor formation is a serious threat in chemotherapy with these drugs, we explored whether and to what extent the DNA repair protein DNA-O6-methylguanine:protein-L-cysteine S-methyltransferase (MGMT) protects against CNU-induced tumors. We made use of transgenic mice overexpressing human MGMT in their skin and the initiation-promotion protocol on treatment with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU, nimustine) that is representative of CNUs. ACNU applied topically as a single low dose to the dorsal skin was highly effective in tumor induction in nontransgenic mice, whereas in cytokeratin MGMT transgenic mice, tumor formation was remarkably reduced. ACNU-induced skin tumors harbored mutations in the c-Ha-ras gene in both groups of mice. The results provide clear evidence that MGMT exerts protection against CNU-induced cancer. Our data also indicate that O6-chloroethylguanine, which is repaired by MGMT, is a main precarcinogenic CNU-induced DNA lesion.
1 Supported by Research Grants Be 1484/1-2 (to K. B.) and Ka 724/4-2 (to B. K.) from the Deutsche Forschungsgemeinschaft.
2 To whom requests for reprints should be addressed, at DNA Repair Group, Institute of Plant Genetics and Crop Plant Research, Corrensstr. 3, D-06466 Gatersleben, Germany.
Received 4/23/97. Accepted 7/ 1/97.
This article has been cited by other articles:
![]() |
R. Nagasubramanian, R. J. Hansen, S. M. Delaney, M. M. Cherian, L. D. Samson, S. C. Kogan, and M. E. Dolan Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure Mutagenesis, May 13, 2008; (2008) gen018v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hansen, R. Nagasubramanian, S. M. Delaney, L. D. Samson, and M.E. Dolan Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice Carcinogenesis, May 1, 2007; 28(5): 1111 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibanez Koref Variability and regulation of O6-alkylguanine-DNA alkyltransferase Carcinogenesis, April 1, 2003; 24(4): 625 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Becker, C. Gregel, C. Fricke, D. Komitowski, J. Dosch, and B. Kaina DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors Carcinogenesis, March 1, 2003; 24(3): 541 - 546. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |